Order byBest matchMost fresh

Novo Nordisk slashes price of Ozempic

Digest more
Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers
Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients with type 2 diabetes in the U.S. via its own pharmacy, a tie-up with telehealth service GoodRx and other platforms.

Continue reading

Novo Nordisk slashes price of Ozempic to $499 for cash-paying, uninsured patients
Novo Nordisk, GoodRx selling Ozempic at half cost for customers paying cash
Canada approves Ozempic to cut risk of kidney failure, heart-related deaths
Canada has approved Novo Nordisk's (NOVOb.CO) diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of kidney failure and heart-related deaths in type-2 diabetes patie...

Continue reading

Ozempic forced to slash prices after problem emerges
Novo Nordisk Soars After 50% Ozempic Discount, Liver Treatment Approval
Novo Nordisk to present Wegovy® and Ozempic® data showing life-saving cardiovascular benefits for people living with obesity and type 2 diabetes at the European Society of Cardiology Congress 2025
“At the ESC congress, we are presenting new data substantiating the unique range of benefits semaglutide has on people with heart and kidney disease, as demonstrated in both clinical trials and in the...

Continue reading

US cash-paying customers can now get Ozempic for half price
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease

Ozempic, other weight-loss drug makers face lawsuits. Here's what we know

A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits totaling more than $2 billion circulated online in August 2025.  Claims of lawsuits against Ozempic and similar drugs are indeed true.

Novo Nordisk Freezes Hiring in Noncritical Areas

The pharma giant has almost doubled the size of its workforce over the last five years but is now looking to tighten cost controls amid challenges in the obesity-drug market.
REVOLT on MSN1d

Ozempic reportedly faces $2 billion in lawsuits over severe side effects

Over 1,800 lawsuits claim Ozempic caused stomach paralysis, vision loss, and more. Read what’s next in the legal fight.

Gynaecologist explains little-known side effects as women detail their experiences of 'Ozempic vulva'

Some women are complaining of 'Ozempic vulva' and GLP-1 medications can causes changes to women's private parts.
Feedback